Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs

Go back to Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs

Incyte (INCY) Reports Q1 Loss of $2.86, Reaffirms Guidance

May 5, 2020 7:23 AM EDT

Incyte (NASDAQ: INCY) reported Q1 EPS of ($2.86), versus $0.62 reported last year. Revenue for the quarter came in at $568.5 million versus the consensus estimate of $556.04 million.

2020... More